Plasma chondroitin sulfate predicts the effectiveness of fluid resuscitation strategies in patients with sepsis.

Saved in:
Bibliographic Details
Title: Plasma chondroitin sulfate predicts the effectiveness of fluid resuscitation strategies in patients with sepsis.
Authors: Oshima K; Department of Medicine, Mass General Brigham, Boston, Massachusetts, USA., Yan B; Department of Biostatistics and., Tao R; Department of Biostatistics and.; Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Amorim G; Department of Biostatistics and., Di Gravio C; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom., McMurtry SA; Department of Medicine, University of Colorado, Aurora, Colorado, USA., Burke RC; Department of Emergency Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA., Nam Y; Department of Biostatistics and., Nikolli I; Department of Medicine, Mass General Brigham, Boston, Massachusetts, USA., Kravitz MS; Department of Emergency Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA., Stephenson D; Department of Biochemistry and Molecular Genetics, University of Colorado, Aurora, Colorado, USA., Issaian A; Department of Biochemistry and Molecular Genetics, University of Colorado, Aurora, Colorado, USA., Hansen KC; Department of Biochemistry and Molecular Genetics, University of Colorado, Aurora, Colorado, USA., D'Alessandro A; Department of Biochemistry and Molecular Genetics, University of Colorado, Aurora, Colorado, USA., Douglas IS; Department of Medicine, University of Colorado, Aurora, Colorado, USA.; Department of Medicine, Denver Health Medical Center, Denver, Colorado, USA., Self WH; Vanderbilt Institute for Clinical and Translational Research and Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Lindsell CJ; Department of Biostatistics and Bioinformatics and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA., Leroux C; Department of Medicine, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA., Ringor A; Department of Medicine, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA., Matthay MA; Department of Medicine, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA., Schildcrout JS; Department of Biostatistics and., Shapiro NI; Department of Emergency Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA., Schmidt EP; Department of Medicine, Mass General Brigham, Boston, Massachusetts, USA.
Source: The Journal of clinical investigation [J Clin Invest] 2026 Feb 03; Vol. 136 (7). Date of Electronic Publication: 2026 Feb 03 (Print Publication: 2026).
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: eCollection Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-8238
DOI:10.1172/JCI202480